Fisetin Modulates Human Oral Squamous Cell Carcinoma Proliferation by Blocking PAK4 Signaling Pathways

OBJECTIVE: Human oral squamous cell carcinoma (OSCC) is a major cause of mortality and morbidity worldwide. There is an urgent need to identify bioactive molecules and potential target genes that could inhibit carcinogenesis for OSCC therapy. Fisetin (3,7,3′,4′-tetrahydroxyflavone), a naturally occu...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yanshu, Jia, Shiheng, Dai, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049269/
https://www.ncbi.nlm.nih.gov/pubmed/32158195
http://dx.doi.org/10.2147/DDDT.S229270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049269/
https://www.ncbi.nlm.nih.gov/pubmed/32158195
http://dx.doi.org/10.2147/DDDT.S229270

Ejemplares similares